Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
We reviewed available research findings, including meta-analyses on effects of lithium-treatment associated with rates of suicidal behavior in bipolar disorder or unipolar major depressive disorder patients, and for comparisons of lithium to mood-stabilizing anticonvulsants. Data from meta-analyses consistently indicate marked reductions of suicidal behavior and mortality during long-term treatment with lithium salts in bipolar disorder patients, and possibly also in unipolar, recurrent major depressive, perhaps even more effectively than with anticonvulsants proposed as mood-stabilizers. Suicidal risk is frequently associated with dysphoric-agitated symptoms, anger, aggression, and impulsivity-all of which may respond better to treatment with lithium or other mood-stabilizing medicines than to antidepressants. In these conditions, antidepressant treatment may not provide a beneficial effect on risk of suicidal thoughts and perhaps attempts, particularly in juveniles, whereas, lithium, perhaps even more than anticonvulsants, seems to be remarkably effective in the preventing suicidal behavior. The mechanism of action is not well defined and may be associated with either a prevention of mood recurrences or a more specific “antisuicidal” activity. Declaration of Interest: Dr. Tondo has received research support from Janssen and Eli Lilly Corporations and has served as a consultant to Glaxo-SmithKline and Merck Corporations. Dr. Baldessarini has recently been a consultant or investigator-initiated research collaborator with: AstraZeneca, Auritec, Biotrofix, Janssen, JDS-Noven, Lilly, Luitpold, NeuroHealing, Novartis, Pfizer, and SK-BioPharmaceutical Corporations. Neither author is a member of pharmaceutical speakers’ bureaus, nor do they or any family member hold equity positions in biomedical or pharmaceutical corporations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Suicide as an outcome for mental disorders: A meta-analysis
Harris, E. C., & Barraclough, B. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.170.3.205 · Cited by 2,589 · cited 1×
“Among these, bipolar disorder (BPD) as well as severe (with hospitalization) recurrent major depression (MDD) have the highest standardized mortality ratio (SMR) of any psychiatric disorders compared with the general population (Harris & Barraclough, 1997; 1998).”
BackgroundThe Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881 · cited 1×
“Among these, bipolar disorder (BPD) as well as severe (with hospitalization) recurrent major depression (MDD) have the highest standardized mortality ratio (SMR) of any psychiatric disorders compared with the general population (Harris & Barraclough, 1997; 1998).”
BackgroundMeltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393 · cited 1×
“…and close supervision required by lithium treatment is not likely to be a critical factor, given experience in the InterSePT trial for schizophrenia patients, which found superior antisuicidal effects of clozapine over olanzapine, despite matching for clinician contact-time (Meltzer et al., 2003).”
BackgroundDecreased risk of suicides and attempts during long‐term lithium treatment: a meta‐analytic review
Baldessarini, R. J., Tondo, L., Davis, P., Pompili, M., Goodwin, F. K., & Hennen, J. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00344.x · Cited by 753
Self-citationPost, R. M., Denicoff, K. D., Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T. M., Rush, A. J., Keck, P. E., McElroy, S. L., Luckenbaugh, D. A., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0610 · Cited by 418
Goldberg, J. F., Perlis, R. H., Bowden, C. L., Thase, M. E., Miklowitz, D. J., Marangell, L. B., Calabrese, J. R., Nierenberg, A. A., & Sachs, G. S. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08050746 · Cited by 322 · cited 2×
“That is, antidepressant treatment may increase the risk of suicidal behavior in vulnerable patients in particular mood-states that can occur spontaneously or perhaps be stimulated by antidepressant treatment itself (Koukopoulos & Koukopoulos, 1999; Akiskal et al., 2005; O’Donovan et al., 2008; Goldberg et al., 2009).”
BackgroundSuicidal risks among 2826 Sardinian major affective disorder patients
Tondo, L., Lepri, B., & Baldessarini, R. J. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01066.x · Cited by 177 · cited 2×
“The very high risk of suicide among BPD patients also was supported by our recent review of the medical records of nearly 3,000 outpatients diagnosed with DSM-IV major mood disorders (Tondo & Baldessarini, 2007).”
BackgroundSelf-citation
Cited by
Inhibition of GSK3 by lithium, from single molecules to signaling networks
Freland, L., & Beaulieu, J.-M. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00014 · Cited by 269
Larkin, G. L., & Beautrais, A. L. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000629 · Cited by 258
RetractedLithium and suicide in mood disorders: Updated meta‐review of the scientific literature
Smith, K. A., & Cipriani, A. (2017) · Bipolar Disorders · doi:10.1111/bdi.12543 · Cited by 247
Discovery and validation of blood biomarkers for suicidality
Le-Niculescu, H., Levey, D. F., Ayalew, M., Palmer, L., Gavrin, L. M., Jain, N., Winiger, E., Bhosrekar, S., Shankar, G., Radel, M., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.95 · Cited by 193
Bolton, J. M., & Robinson, J. (2010) · American Journal of Public Health · doi:10.2105/ajph.2010.192252 · Cited by 165
Metadata
- Authors
- Tondo, L., & Baldessarini, R. J.
- Venue
- Epidemiologia e Psichiatria Sociale
- Publisher
- Cambridge University Press (CUP)
- Published
- 2009-09
- Volume
- 18
- Issue
- 3
- Pages
- 179-183
- ISSN
- 1121-189X (ISSN-L)
- 2038-1816
- OpenAlex
- W2265480533
- Cited by
- 79
- References
- 8
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. https://app.cochat.ai/papers/10.1017/s1121189x00000439
- The paper
- Tondo, L., & Baldessarini, R. J. (2009). Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiologia e Psichiatria Sociale. https://doi.org/10.1017/s1121189x00000439
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.